Taken together, our data on IL-1 and TGF-β expression in acquired cholesteatoma support the hypothesis that in more symptomatic cholesteatomas, activation of proinflammatory pathways could lead to increased TGF-β expression, which is one of the most relevant factors involved in cell proliferation and migration [18,27]. The gene discussed is IL1A; the disease is cholesteatoma.